Gut microbiota and metabolomics in metabolic dysfunction-associated fatty liver disease: interaction, mechanism, and therapeutic value

The global epidemic of Metabolic dysfunction-associated fatty liver disease (MAFLD) urgently demands breakthroughs in precision medicine strategies. Its pathogenesis centers on the cascade dysregulation of the gut microbiota-metabolite-liver axis: microbial dysbiosis drives hepatic lipid accumulatio...

詳細記述

書誌詳細

出版年:	Frontiers in Cellular and Infection Microbiology
主要な著者:	Luyu Wang, Hongtao Wang, Jian Wu, Changyi Ji, Ying Wang, Mengmeng Gu, Miaomiao Li, Hongwei Yang
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2025-07-01
主題:	metabolic dysfunction-associated fatty liver disease (MAFLD) gut microbiota metabolomics gut-liver axis precision medicine
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fcimb.2025.1635638/full